EP 0730588 A1 19960911 - ISOXAZOLINE COMPOUNDS AS ANTIINFLAMMATORY AGENTS
Title (en)
ISOXAZOLINE COMPOUNDS AS ANTIINFLAMMATORY AGENTS
Title (de)
ISOXAZOLINVERBINDUNGEN ALS ENTZÜNDUNGSHEMMENDE MITTEL
Title (fr)
COMPOSES D'ISOXAZOLINE UTILES COMME AGENTS ANTI-INFLAMMATOIRES
Publication
Application
Priority
- IB 9400333 W 19941026
- US 15724893 A 19931126
- US 26208694 A 19940617
Abstract (en)
[origin: US5716967A] PCT No. PCT/IB94/00333 Sec. 371 Date May 15, 1996 Sec. 102(e) Date May 15, 1996 PCT Filed Oct. 26, 1994 PCT Pub. No. WO95/14681 PCT Pub. Date Jun. 1, 1995This invention relates to isoxazoline compounds which are selective inhibitors of phosphodiesterase type IV (PDEIV). The isoxazoline compounds are useful in inhibiting PDEIV and in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease, psoriasis, allergic rhinitis, dermatitis, shock, atopic dermatitis, rheumatoid arthritis and osteoarthritis. This invention also relates to pharmaceutical compositions useful therefor.
IPC 1-7
IPC 8 full level
C07D 261/08 (2006.01); A61K 31/42 (2006.01); A61K 31/423 (2006.01); A61K 31/425 (2006.01); A61K 31/47 (2006.01); A61P 11/00 (2006.01); A61P 17/00 (2006.01); A61P 29/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 261/04 (2006.01); C07D 261/18 (2006.01); C07D 261/20 (2006.01); C07D 413/12 (2006.01); C07D 417/06 (2006.01)
CPC (source: EP KR US)
A61K 31/42 (2013.01 - KR); A61P 11/00 (2018.01 - EP); A61P 17/00 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 261/04 (2013.01 - EP KR US)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9514681 A1 19950601; AT E154932 T1 19970715; AU 687452 B2 19980226; AU 7821894 A 19950613; BR 9408174 A 19970527; CA 2176255 A1 19950601; CA 2176255 C 19990223; CN 1046274 C 19991110; CN 1136314 A 19961120; CO 4180606 A1 19950607; CZ 151096 A3 19970115; CZ 283564 B6 19980513; DE 69404044 D1 19970807; DE 69404044 T2 19971016; DK 0730588 T3 19971208; EG 20693 A 19991130; EP 0730588 A1 19960911; EP 0730588 B1 19970702; ES 2104424 T3 19971001; FI 945557 A0 19941125; FI 945557 A 19950527; GR 3024133 T3 19971031; HU 9601412 D0 19960729; HU T76784 A 19971128; IL 111670 A0 19950124; IL 111670 A 19980816; JP 2802547 B2 19980924; JP H09500147 A 19970107; KR 0182324 B1 19990501; KR 960705795 A 19961108; NO 962127 D0 19960524; NO 962127 L 19960524; NZ 274244 A 19970922; PE 33495 A1 19951027; PL 314605 A1 19960916; US 5716967 A 19980210
DOCDB simple family (application)
IB 9400333 W 19941026; AT 94929001 T 19941026; AU 7821894 A 19941026; BR 9408174 A 19941026; CA 2176255 A 19941026; CN 94194274 A 19941026; CO 94053701 A 19941124; CZ 151096 A 19941026; DE 69404044 T 19941026; DK 94929001 T 19941026; EG 74594 A 19941124; EP 94929001 A 19941026; ES 94929001 T 19941026; FI 945557 A 19941125; GR 970401783 T 19970716; HU 9601412 A 19941026; IL 11167094 A 19941117; JP 51493395 A 19941026; KR 19960702761 A 19960525; NO 962127 A 19960524; NZ 27424494 A 19941026; PE 25554294 A 19941124; PL 31460594 A 19941026; US 64094496 A 19960515